COVID-19 news from experts at Columbia University Irving Medical Center. Visit our Coronavirus Resource Center for the latest COVID-19 information for CUIMC providers, staff, students, researchers and patients.
Search All News
The latest omicron subvariants—especially the currently dominant BA.4 and BA.5 forms—are even better at eluding vaccines and most treatments, find researchers at Columbia University.
Community outreach and restricting online scheduling to certain zip codes helped increase vaccine uptake among Black and Hispanic residents, new study says.
- March 22, 2021
With more patients complaining of lingering and chronic effects from COVID-19, Columbia experts review what’s known and why care for long-haulers requires an interdisciplinary approach.
- March 15, 2021
A real-time study of immune responses inside the lungs of COVID patients suggests a cytokine “hurricane” in the airways drives severe disease, and an influx of T cells may be critical to survival.
- March 11, 2021
New videos from Hip Hop Public Health, a community organization founded by a Columbia neurologist, are using the power of music to help increase COVID-19 vaccine coverage in communities of color.
- March 10, 2021
Jessica Justman, MD, an infectious disease specialist and epidemiologist at Columbia, says vaccinated people still need to take some precautions for now.
- March 9, 2021
Columbia fertility experts have developed a one-step saliva test for diagnosing COVID-19 that could expand access to testing.
- March 8, 2021
A virtual town hall hosted by CUIMC and NewYork-Presbyterian Hospital brought together community health workers and local leaders to discuss questions and concerns regarding the COVID-19 vaccines.
- March 8, 2021
New Columbia study suggests current vaccines and monoclonal antibody therapies provide less neutralizing activity against the U.K. and South Africa variants of SARS-CoV-2.
- March 5, 2021
The third authorized vaccine provides protection, particularly against severe illness and death, with just one shot, says Columbia's Jason Zucker, MD.
- March 4, 2021
A systematic screening program designed for athletes testing positive for COVID-19 has detected a low incidence of inflammatory heart disease, so far returning professional athletes safely to sport.